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Abstract
Background: A widespread assumption across health systems suggests that greater clinicians’ involvement in
governance and management roles would have wider benefits for the efficiency and effectiveness of healthcare
organisations. However, despite growing interest around the topic, it is still poorly understood how managers with
a clinical background might specifically affect healthcare performance outcomes. The purpose of this review is,
therefore, to map out and critically appraise quantitatively-oriented studies investigating this phenomenon within
the acute hospital sector.
Methods: The review has focused on scientific papers published in English in international journals and conference
proceedings. The articles have been extracted through a Boolean search strategy from ISI Web of Science citation
and search source. No time constraints were imposed. A manual search by keywords and citation tracking was also
conducted concentrating on highly ranked public sector governance and management journals. Nineteen papers
were identified as a match for the research criteria and, subsequently, were classified on the basis of six items.
Finally, a thematic mapping has been carried out leading to identify three main research sub-streams on the basis
of the types of performance outcomes investigated.
Results and contribution: The analysis of the extant literature has revealed that research focusing on clinicians’
involvement in leadership positions has explored its implications for the management of financial resources, the
quality of care offered and the social performance of service providers. In general terms, the findings show a
positive impact of clinical leadership on different types of outcome measures, with only a handful of studies
highlighting a negative impact on financial and social performance. Therefore, this review lends support to the
prevalent move across health systems towards increasing the presence of clinicians in leadership positions in
healthcare organisations. Furthermore, we present an explanatory model summarising the reasons offered in
the reviewed studies to justify the findings and provide suggestions for future research.
Keywords: Clinical leadership, Hospital performance, Narrative review
Background
Over the last three decades healthcare organisations (in
particular hospitals) have progressively adopted models
of governance alternative to the traditional ‘professional
bureaucracy’ [1], which are influenced by the manager-
ialist ideology [2]. In the public sector, these changes
have signified a ‘corporatisation’ of hospitals towards a
business-like form [3], in the aim to extend the inde-
pendence of decision making’ [4]. This shift has implied
the introduction of significant structural changes in
leadership positions, namely the creation of the Chief
Executive Officer (CEO) role and the appointment of
boards of directors [5]. Following the fundamental
underlying assumption in corporate governance that bet-
ter governance mechanisms lead to greater efficiency
and effectiveness of organisations, the adoption of these
business-like governance arrangements has been seen as
crucial for performance improvements in private (profit
and non-profit) and public hospitals.
While these reforms have been largely supported in re-
lation to increased organisational autonomy and greater
independence in strategic decision making processes [6],
what is the most effective bundle of expertise and skills
of hospital senior leaders has remained an open issue. In
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this sense, scholars and practitioners have questioned
whether the hospital CEO and the board directors
should be clinically-trained top managers [7–10]. Empir-
ical evidence suggests that the extent to which clinicians
are involved in leadership positions varies greatly across
countries. For instance, analysing a sample of 6,500 US
hospitals Gunderman and Kanter [11] report that only
235 organisations were led by doctors. Similar conclu-
sions are drawn in the UK, where Veronesi et al. [12]
suggest that on average individuals with a clinical back-
ground make up over a quarter of the board members
(26.03 %) and represent about 22 % of the hospital
CEOs. Markedly different conclusions are, on the other
hand, reported in relation to healthcare organisations in
continental Europe. Indeed, comparative research high-
lights how doctors represent the majority of senior man-
agers in most European hospital systems such as Italy
(50 %), France (63 %) and Germany (71 %) [13].
What the available research has in the main suggested
is that greater clinicians involvement in leadership posi-
tions, especially at the strategic level, has potentially im-
portant benefits for healthcare outcomes [12, 14–17].
Accordingly, it has been pointed out that ‘in a healthcare
system that is complex, troubled, and challenging, the
doctor CEOs and board directors bring a unique set of
skills to the business of medicine’ [10], as they better
understand clinical challenges and general patients’
needs [18, 19]. Additionally, they can ensure better com-
munication with clinically-qualified personnel as well as
enjoying greater legitimacy [13, 20]. Thus, through
greater involvement of clinicians at the strategic level,
hospitals not only will benefit from a higher quality of
strategic decisions, but also from a more concrete imple-
mentation of decisions taken.
Yet, although the evidence shown in these studies
seems supportive, questions remain about the impact of
clinical leadership on overall hospital performance. For
instance, concerning the consequences of clinical in-
volvement for the quality of the service provided, while
Goodall [7] reports a significant relationship between
clinical CEOs and organisational performance in the US,
Veronesi et al. [12] do not observe any significant associ-
ation between the clinical background of the CEO and
service quality. The apparent inconclusiveness of the ex-
tant research is even more obvious if we consider the
impact of clinical leadership on hospital financial per-
formance. On the one hand, a number of studies show
that clinically-qualified managers positively affect hos-
pital financial efficiency [14]. Conversely, other studies
in the US and Italy highlight a negative impact of clinical
leadership on the efficient management of hospital re-
sources [21, 22].
Thus, while the possibility that clinicians’ involvement
could be beneficial for hospital has been recognized [13],
to what extent managers with a clinical background
might specifically affect different types of hospital per-
formance outcomes is still poorly understood. Indeed, to
our knowledge there has been no systematic review of
the quantitative evidence investigating this phenomenon.
Therefore, the purpose of the paper is to fill this gap by
mapping out and critically appraise quantitatively-oriented
studies analysing the association between clinicians’ in-
volvement in senior leadership positions (i.e. CEO, top
management and board of directors) and hospital perform-
ance. This represents a much needed contribution consid-
ering that a positive impact on performance outcomes
underpins the widespread drive for enhancing clinical lead-
ership in healthcare organisations [23]. Furthermore, the
paper builds on the evidence reported by presenting an
explanatory model, where reasons for the positive/negative
impact of clinical leadership are offered.
The remainder of this paper is structured as follows.
Section 2 presents the review method. Section 3 illustrates
the findings and the literature systematization. Section 4
concludes by presenting the explanatory model and offer-
ing suggestions for future research on this topic.
Review method
Following previous literature [24, 25], our systematic re-
view is based on a narrative approach. This is consistent
with the aim of our study of summarizing and interpret-
ing key findings of research exploring the involvement
of clinicians in governance roles and its impact on
hospital performance, as well as recognizing different
narratives of the phenomenon. To identify the relevant
articles, we have focused on scientific papers published
in English in both peer-reviewed international journals
and conference proceedings. This is a standard practice
in literature reviews since these sources are considered
‘certified knowledge’ which enhances the reliability of
the analysis [26]. We have not imposed time constraints
on the search process to be able to capture all relevant
contributions until June 2015 (Fig. 1).
In order to extract relevant papers, we have conducted
Boolean searches using truncated combinations of two
groups of search strings [27]. While one string covers
the performance realm, the other one includes keywords
referred to clinical leadership. We applied these criteria
to the ISI Web of Science citation and search source.
We searched for all papers whose title, publication, ab-
stract and keywords included at least a string belonging
to one of the two selected sets. We have opted for this
database because it is considered the largest, most com-
monly used and generally accepted source for literature
reviews [26, 27]. After removing potentially duplicated
articles, the search returned 253 papers. To assess the
relevance and consistency of these studies with the se-
lection criteria, each of them was evaluated in relation
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to title, keywords, abstract and, when necessary, full text.
This selection process was carried out by the two au-
thors only focusing on quantitative empirical studies.
We decided to not consider qualitatively-oriented arti-
cles as their findings are not generalizable. Eventually,
we excluded 245 not relevant articles. Furthermore, fol-
lowing the process adopted in previous literature reviews
[28], our search was completed by manually looking and
tracking citations for additional relevant articles in
highly ranked healthcare management journals. There-
fore, the final sample consists of 19 papers (8 identified
through database search and 11 from the manual search
and citation tracking phase).
Following a standard approach in systematic literature
reviews [26, 27], we have analysed and classified the
selected papers according to the following criteria: re-
search settings, type of organisation, type of analysis,
sample size, leadership position, performance dimension,
performance proxy, and effect of clinical leadership on
organisational performance. Finally, in order to better
interpret the findings of the studies included in the
final sample and to fully understand the explanations
provided for the reported results, a thematic mapping
of the articles was carried out [24]. We iteratively
identified the key themes and independently analyzed
the articles and discussed their conclusions. This
process has allowed us distinguishing three main re-
search sub-streams according to the performance out-
comes used as dependent variable(s): (i) management
of financial and operational resources, (ii) quality of
the care provided and (iii) social performance of the
hospital. More specifically, while articles belonging to
the first stream investigate the implication of clini-
cians’ involvement in leadership positions for financial
performance, the second and the third ones mainly
explore the effect on non-financial performance.
Fig. 1 Research Design
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Analysis of the literature
Table 1 provides an overview of the selected articles.
These studies have been conducted between 1993 and
2015, with the majority of them (63 %) published in the
last decade (2006–2015). The results of the categorisa-
tion process show that most of the articles focused on
US settings (74 %). Nevertheless, studies based on the
German, Italian and British health systems are also rep-
resented in the final sample. Concerning the type of
organisations investigated, most papers (60 %) focused
on private healthcare organisations, in both for-profit
and not-for-profit sectors, while relative less attention
has been devoted to public sector hospitals (35 %). This
can be explained by the fact that the early studies almost
exclusive concentrated on the US health system. Regard-
ing the type of analysis conducted, the majority of the
studies (84 %) have employed a cross-sectional approach,
with a minor percentage adopting longitudinal data ana-
lysis (11 %) and simulation techniques (5 %). The aver-
age size of the investigated samples stood at around 237
organizations, although there are wide variations be-
tween studies (from 2 to 1,220). With reference to lead-
ership positions, the extant literature has mainly
investigated the involvement of clinicians in boards of
directors (60 %) and in CEO positions (20 %), with a re-
sidual percentage focusing on top executives, quality
committee and medical director positions. Finally, with
regard to the performance dimension, most studies have
focused on the impact of clinically-qualified managers
on financial or operational performance (59 %), which is
not too surprising considering the prevalence of private
organisations as research setting. Furthermore, although
the majority of the studies analysed only one dimension
of organisational performance, some articles have fo-
cused on both financial and non-financial (including
social) performance outcomes (21 %) (Fig. 2).
Beyond these stylised facts, in the large majority of the 19
identified papers the effect of clinical involvement in leader-
ship positions on organisational performance was found to
be positive. Only three articles showed a negative impact of
clinical leadership on organisational outcomes and more
specifically on financial performance, and one study
highlighted a negative effect on social performance. In the
following sub-sections, we present the three sub-streams of
the literature that emerged from the thematic mapping of
the papers. This analysis suggests that the extant literature
has mainly focused on the influence of clinical leadership
on the efficient management of resources, the quality of
care provided and the social performance of the hospital.
Clinical leadership and the management of financial and
operational resources
Among the studies exploring the impact of clinical lead-
ership on organisational performance, the earliest
research sub-stream has focused on its implications for
the efficient management of financial and operational
resources. These performance outcomes have been typ-
ically associated with measures of profitability (such as
operating margin and overall profit generated), oper-
ational efficiency (bed occupancy rate) and, in few cases,
market power (market share). This line of research was
firstly developed in the US, where a notable proportion
of the acute care provision was (and still is) delivered in
private hospitals. However, more recently, this attention
to bottom line profitability and competitiveness has also
emerged in Europe, in particular as a consequence of
the new public management reforms. These reforms
have indeed given prominence to efficiency improve-
ments in public sector hospitals in order to make them
more business-like [4]. The findings of the studies classi-
fied into this sub-stream are not unanimous.
Thus, Goes and Zhan [29] empirically show that
greater doctor involvement in the governance of US pri-
vate acute care hospitals leads to higher bed occupancy
and operating margins. Similar conclusions are reported
by Molinari et al. [30], who highlight how greater med-
ical staff representation on the board of directors is
significantly associated with improved hospital finan-
cial performance in terms of profitability, liquidity as
well as capital structure and intensity. In a later study,
the same authors reinforce these findings by showing
that boards with clinicians have significantly better fi-
nancial performance than boards without any doctor
participation [31]. Also focusing on US settings, Prybil
[32] finds that non-profit general hospitals outperform
the private sector counterparts in terms of overall
profitability when doctor involvement in governance
roles is higher.
Other studies have investigated the effect of clinician
involvement in governance roles for hospital oper-
ational efficiency. Accordingly, Goldstein and Ward
[33] empirically test the implications of the involve-
ment of doctors in top management positions. Their
results support the hypothesis of improved hospital
performance in terms of operational efficiency mea-
sured as beds occupancy rate and market share. Simi-
lar results are reported by Veronesi et al. [14] in a
study focused on the English National Health Service
(NHS). More specifically, the authors highlight a posi-
tive impact of clinical participation on boards of direc-
tors of acute care hospital trusts on the financial
management of their resources.
Several explanations are offered to motivate the bene-
fits of clinical leadership for the management of financial
and operational resources. On the one hand, it is said
that clinician involvement in hospital management
has been partially driven by pragmatic concerns
associated with pressures to control expenditure [12].
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Accordingly, Succi and Alexander [21] state that the
involvement of doctors in top management positions
is frequently sought to reinforce their ‘commitment to
cost containment’; that is, doctors turned managers
would be influenced in their attitudes and behaviours,
and would consequently facilitate the ‘adoption of
more cost efficient clinical practices’. There is, indeed,
evidence suggesting that clinical leadership can
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positively stimulate the behaviour of front line staff.
For instance, Dorgan et al. [20] posit that managers
with a clinical background have more credibility
among clinical staff and thus they are more likely to
influence the behaviour of their colleagues than non-
medical managers. Similarly, it has been observed that
in the presence of clinical leadership front-line staff
will be less likely against adopting cost-efficient clin-
ical practices as there will be less concerns that the
proposed changes will negatively influence the quality
of the service provided [14].
In spite of the growing number of studies supporting
the advantages generated by clinical leadership for the
management of hospital financial and operational re-
sources, some scholars have found evidence of a negative
impact. For instance, Succi and Alexander [21] show
that the main effect of doctor involvement in hospital
management is not related to greater hospital effi-
ciency, but, on the opposite, to lower efficiency. Same
conclusions are drawn by Sarto et al. [22], whose find-
ings indicate that CEOs with a medical background
have a negative impact on financial performance,
calculated as operating margin and financial efficiency,
although the evidence seems to suggest that the im-
pact is lower in the case of medical CEOs with previ-
ous managerial expertise.
Substantially, it cannot be excluded that the involve-
ment of clinicians in leadership positions can be also
counter-productive. This is also conceptually argued by
studies not included in the sample but cited. For in-
stance, Mannion et al. [34] find that in hospitals
dominated by ‘pro-professional cultures’, strategic and
operational decisions can be oriented towards meeting
clinical needs at the expense of financial performance
targets. Additionally, it has been noticed that when doc-
tors in governance roles gain awareness of the trade-offs
faced by managers between financial concerns and clin-
ical priorities, the differences between management and
medical worlds can intensify rather than being solved
[21]. Moreover, some authors argue that clinical man-
agers can experience strong role conflict when moving
into managerial roles which in turn affects their strategic
decision making. In this instance, clinically-qualified
managers would prioritise clinical needs at the expense
of financial efficiency and cost containment [23].
In line with the findings reported by Sarto et al. [22],
an additional line of inquiry has recently suggested
that doctors performing managerial roles could be less
effective than managers without a clinical background
in the financial management of resources when they
lack a proper managerial training before taking on the
role [14]. Accordingly, Kippist and Fitzgerald [35] rec-
ognise that among ‘barriers to the effectiveness of the
role of hybrid clinician manager’ it is well recognized
‘the lack of management education and skill’. Simi-
larly, Falcone and Satiani [10] state that a ‘successful
physician leader must understand the business of
medicine as well as or better than he or she under-
stands the practice of medicine’.
Clinical leadership and the quality of care provided
A growing number of studies has focused on the impact
of clinical leadership on the quality of care provided,
measured by process and outcomes indicators. It is im-
portant to notice that all the studies (bar one exception)
included in this review have reported empirical results
that strongly support the positive beneficial effects of the
presence of clinicians in leadership roles for the quality
of care offered in hospitals.
With reference to the US context, Prybil [32] analyses
a sample of 14 non-profit general hospitals and finds
that the top high performing hospitals are characterised
by a higher involvement of doctors in management than
the mid-range performers where the performance indi-
cators are a quality of care rating and a patient satisfac-
tion score. Similarly, Bai and Krishnan [36] report that
non-profit hospitals without doctor participation on
their boards are more likely to deliver lower quality of
care, proxied by the process of care quality rating of the
Hospital Quality Alliance. Furthermore, focusing only on
hospital board quality committees, Jiang et al. [15] show
that having a higher doctor participation on committees
strongly improves hospital performance in terms of the
care process (measured as quality of care of heart attack,
heart failure, pneumonia, and surgical infection preven-
tion) and mortality rates.
Similarly, Goodall [7], focusing on the top 100 US hos-
pitals according to the Index of Hospital Quality ranking
of the US News and World Report, finds that having a
CEO with a medical background generates greater qual-
ity improvements that result in a higher quality ranking
for the hospital. Comparable conclusions are also re-
ported by Goodall et al. [37]. In this study, the authors
highlight how the US’s top 10 psychiatric hospitals, as
ranked by the US News & World Report, are exclusively
managed by CEOs with a medical background. Differ-
ent conclusions are drawn by Schultz and Pal [38],
who examine the ability of CEOs of integrated health-
care organisations to make effective strategic deci-
sions. More specifically, the study reveals no significant
differences between medically-educated and managerially-
educated senior managers in their ability to make strategic
decisions that maximize the quality of care provided by
the organisation.
Turning our attention to the European settings,
Veronesi et al. [12] report that a greater ratio of clinical
members on governing boards of English hospital trusts
generates better ratings of the quality of the service
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provided, as well as being associated with a reduction
in morbidity rates. In a later study, Veronesi et al.
[39] also show that the involvement of clinicians on
the board of directors improves the overall patient
experience of the care provided by acute hospitals
when clinical managers operate in a more autono-
mous organisational form. A similar methodology was
also applied to the Italian NHS, where Sarto and col-
leagues [22] find a positive correlation between the
clinical background of public hospital CEOs and qual-
ity outcomes, measured as medical and surgical ap-
propriateness as well as patient length of stay in
hospital. Finally, focusing on a sample of German
hospitals, Kuntz and Scholtes [40] suggest the exist-
ence of a positive relationship between a full-time or
heavily involved part-time medical director and a
higher staff-to-patient ratio, a common measure of
quality and safety of the healthcare process.
By deepening also studies not included in the sample,
the positive outcomes of the presence of clinically-
qualified managers for the quality of the service provided
are explained in a variety of ways. First, it is suggested
that the involvement of clinicians in strategic decision
making represent the most effective option to achieve
the critical link between strategic planning and its
implementation at the clinical level [33]. Accordingly,
Llewellyn [41] notes that managers with a clinical
background are in a privileged position to bridge the
historical divide between the worlds of cure, care and
administration. Essentially, the assumption is that doc-
tors can more easily acquire management expertise
while a non-clinical manager would find more difficult
to gain sufficiently appropriate medical knowledge. In
this sense, some authors state that the involvement of
doctors provides unique advantages to the organisa-
tional strategic decision making process due to their
crucial knowledge as well as their exclusive relation-
ship with patients [18, 19]. Thus, according to Ford-
Eichkoff et al. [42], increasing the number of board
members with clinical background provides governing
boards with a greater breadth of expertise. Similarly,
Dorgan et al. [13] claim that clinician involvement in
hospital governance leads to an improvement in man-
agerial decision making quality, as they can better
understand clinical challenges and general patient
needs and they can more effectively communicate with
clinical staff. Additional studies suggest that high per-
forming medical top management teams tend to be
those with more ‘quality-centred cultures’ [43].
Finally, other authors emphasise how managers with
clinical background will not only improve the quality
of hospital decision making, but they will be seen as
credible leaders and hence will be more likely to at-
tract talented medical personnel [10].
Clinical leadership and the hospital social performance
A third sub-stream of studies that emerged from the
analysis focuses on the impact of clinical leadership on
hospital social performance. These articles are generally
more recent and only focus on private healthcare organi-
sations, being all based in the US.
Thus, Bai [44] shows that the occupational back-
ground of board members influences the hospital
social performance. More specifically, the author finds
that in for-profit hospitals the presence of doctors on
governing boards is positively correlated with hospital
social performance, which is measured as a multi-
dimensional construct capturing hospital expenditure
on community benefits. Similar results are reported in
a study by De Andrade Costa [45], also focused on the
private hospital sector. The evidence highlights how
increased medical membership of boards positively re-
lates to higher levels of uncompensated care provision,
thus improving the benefits for the community. The
author justifies these results by stating that the ethical
beliefs and professional norms of doctors enhance the
probability of serving the best interest of patients even
in the absence of financial benefits. Considering all the
above, it can be concluded that clinical involvement in
top management positions increases the pressure on
the governing board to enhance the provision of un-
compensated care and, as a consequence, boosts over-
all hospital social performance [46].
Nevertheless, opposite conclusions are reported by
Brickley et al. [47], who investigate the potential conflict
of interest in non-profit hospitals between donors and
doctors. In this instance, a negative relationship between
doctor representation on the governing board and the
amount of private donations is found. The explanation
provided for this finding is that donors would be deterred
to provide resources to the hospital due to the risk that
these were subsequently expropriated by doctors. Accord-
ingly, in some studies [48] it is suggested that private
doctors are more likely to use hospital resources to
maximize their own income rather than directing the
funding received towards the types of investment pre-
ferred by donors, normally oriented towards community
benefits at large. The risk of potential expropriation of
hospital resources leads to a reduction in the amount pri-
vate donations and, hence, a lower likelihood of positive
social performance for private hospitals [49].
Conclusions
Following the growing interest of policy makers and
practitioners in the involvement of clinicians in the
governance and management of healthcare organisations
[9, 50], research conducted on this topic has suggested
that greater clinician participation at the strategic deci-
sion making level potentially has a wide range of benefits
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for hospitals. This systematised review of the literature
highlights how quantitative analyses of this phenomenon
have developed along three main sub-streams. More
specifically, the extant research has explored the implica-
tions of clinical leadership for the management of finan-
cial and operational resources, the quality of care
provided and hospital social performance. Although
based on a relatively limited number of studies, our ana-
lysis overwhelmingly supports the assumption that
greater clinical presence is beneficial for hospital deci-
sion making processes, which clearly has important im-
plications for policy and practice. Fundamentally, clinical
leadership has been found to enhance efficiency and
effectiveness of hospitals along a number of performance
indicators [12, 14–17]. However, while there is a growing
body of evidence to support this conclusion, there are
also reasons to question the assumption that the influ-
ence will necessarily be positive.
To further understand the results of this review, in
Fig. 3 we present an explanatory model that offers a brief
recap of the evidence-base as well as the motivations
provided for the positive and negative impact of clinical
leadership on hospital performance.
As shown in the figure, it is suggested that the beneficial
impact of greater clinician involvement has been justified
by the following reasons: (i) greater provision of critical
knowledge for the decision making process and consequent
improvement of the overall decision making quality; (ii)
higher credibility of clinical leaders and related higher
adoption of hospital policies by medical staff; (iii) improved
organisational credibility and reputation and therefore
higher likelihood of attraction of talented personnel; (iv)
reinforcement of medical commitment to cost contain-
ment; (v) greater attention to patients needs due to ethical
beliefs and professional norms of clinicians. Conversely, the
negative implications for the management of financial re-
sources and hospital social performance have been linked
to the following motives: (i) emergence of conflicts between
clinicians-turned managers and career managers, (ii) rise of
role conflicts in managers with a clinical background
and consequent decisions made at the expense of fi-
nancial performance to protect clinical needs; (iii) lack
of managerial and accounting expertise of clinically-
qualified managers; and (iv) conflicts of interest of pri-
vate doctors in leadership positions.
Despite the evidence overwhelmingly pointing
towards a positive impact of clinical leadership on
hospital performance, there is clearly scope to fur-
ther investigate the phenomenon. First, the large majority
of the studies have used a cross-sectional approach mainly
through OLS regressions to examine the relationship.
Hence, it would be worth conducting further investigation
based on longitudinal data that adopt different methodo-
logical approaches such as panel data (i.e. cross-sectional
time series data) with the related beneficial consequences.
For instance, through panel data analysis not only varia-
tions between firms but also within firms (and so their
behaviour across time) could be accounted for. Further-
more, a panel data approach would control for endogene-
ity issues between variables and unobserved heterogeneity.
Employing a fixed-effects estimator (if appropriate) would
further help with unobserved factors such organisational
culture, age of the hospital facilities and so forth. Panel
data is also suitable for including variables at different
levels of analysis (for instance individual, organisational
and system levels). Essentially, the results of the empirical
analysis would be more robust and generalizable.
Apart from methodological concerns, it appears that
the large majority of the studies have focused on the
Anglo-American context, with only a handful of papers
based on other European health systems. Without deny-
ing the importance of lessons drawn from the UK and
the US health systems, there seems to be a clear need to
expand research to other countries. In this way, it would
be possible to analyse the impact of country-specific
governance models. For instance, in France the hospital
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governance structure is dramatically different from the
Anglo-American model with a far greater presence of
clinicians on advisory boards. However, there is no deny-
ing that the hospital corporatisation process has led to a
widespread adoption of the governing board model typ-
ical of the Anglo-American context in countries such as
Belgium, the Netherlands, Portugal, Spain, and so forth
[5]. Similarly, it would be interested to draw compari-
sons between health systems that follow either the
Beveridge or the Bismarkian model. Additionally, we
would welcome more ambitious studies that directly
take a multi-country approach. So far, only Dorgan et al.
[13] have ventured down this line of research but their
study is limited in scope (mainly focused on investi-
gating the impact of management systems) and meth-
odologically weak. As far as we are aware, there is also
a dearth of research from countries outside North
America and Europe. This line of research could use-
fully expand the emerging evidence on the importance
of hospital governing board oversight on safety and
quality concerns and the role played by clinicians in
this respect [24, 51].
A further line of useful (if not needed) research could be
developed by focusing at the middle and junior manage-
ment levels. The role played by clinicians at the strategic
decision making level is obviously crucial, as shown by the
studies analysed in this review, however more needs to be
understood on the type of impact clinical leadership has at
the operational level. The large majority of hospitals (at
least in the developed world) have adopted the John
Hopkins Hospital clinical directorate model, where a clin-
ician is given managerial responsibilities in relation to
human and financial resources and is held accountable for
the performance of the directorate. The extensive adop-
tion of this organisational model lends itself to a compara-
tive research design, especially considering that there is
already qualitative evidence suggests that the implementa-
tion of clinical directorates has led to different interpreta-
tions and practices across countries [52].
Finally, quantitative approaches can show the exist-
ence of a positive relationship (and the direction of
influence) between clinical leadership and hospital per-
formance, but they cannot explain the why and how. So
far, most of the explanations provided (summarised in
Fig. 3) are essentially based on educated assumptions
derived from a handful of qualitative studies. Expertise
at the individual and clinical levels is undoubtedly cru-
cial, but it still far from clear how far other potential
explanatory factors relating to, for instance, the leader-
ship style of clinicians, the hospital cultural context, and
directors’ collective behaviour within boards are influen-
cing the impact of clinical leadership [53]. So, we would
also encourage further investigation based on in-depth
qualitative approaches, perhaps by observing hospital
board meetings or by interviewing/surveying hospital
senior leaders.
Besides the identifications of research gaps and the
suggestion for future studies, a reference to the theoret-
ical implications of the findings reported by our review
is worthy of note. While more work is indeed needed, we
can conclude that our explanatory model supports the
reasoning underpinning clinical leadership and is in line
with the policy makers’ effort to support the development
of clinicians in leadership position. There is also growing
evidence suggesting that clinicians are increasingly seeing
in positive terms their involvement in managerial posi-
tions, and this hybrid role is becoming engrained in their
understating of professional responsibilities and duties
[54, 55]. This is linked to what Noordegraaf [56] defines
as ‘organizing professionalism’, essentially a new form of
hybrid professionalism. This categorisation reflects the
emergence of clinical professionals who are no longer
solely engaged with providing care to patients, but they
also are involved in the organizing of the healthcare
organization they are working for. In this sense, organizing
becomes an embedded component of professional work
centring around activities such as the arrangement of
inter-professional collaboration, the design and implemen-
tation of innovative projects, the management of scarce
resources, the alignment of decision processes in accord-
ance with financial constraints, and the management of
relationship with multiple stakeholders.
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